AstraZeneca
AZN
#65
Rank
A$367.70 B
Marketcap
A$237.09
Share price
1.23%
Change (1 day)
6.23%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: A$367.70 Billion

As of September 2026 AstraZeneca has a market cap of A$367.70 Billion. This makes AstraZeneca the world's 65th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$367.70 B-14.45%
2025A$429.79 B31.3%
2024A$327.34 B6.62%
2023A$307.02 B-0.69%
2022A$309.16 B23.51%
2021A$250.30 B46.94%
2020A$170.34 B-8.87%
2019A$186.92 B39.46%
2018A$134.03 B20.1%
2017A$111.60 B16.65%
2016A$95.67 B-19.38%
2015A$118.68 B8.45%
2014A$109.43 B31.73%
2013A$83.07 B47.27%
2012A$56.40 B-4.45%
2011A$59.03 B-7.86%
2010A$64.07 B-15.49%
2009A$75.81 B-9.93%
2008A$84.17 B17.96%
2007A$71.36 B-31.43%
2006A$104.06 B-2.45%
2005A$106.67 B37.98%
2004A$77.30 B-29.84%
2003A$110.19 B2.94%
2002A$107.04 B-32.83%
2001A$159.36 B-2.03%
2000A$162.66 B44.16%
1999A$112.83 B62.09%
1998A$69.61 B32.74%
1997A$52.44 B57.08%
1996A$33.38 B

End of Day market cap according to different sources

On Sep 26th, 2026 the market cap of AstraZeneca was reported to be:

A$367.66 Billion
by Nasdaq info icon info icon
A$367.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$930.28 B 153.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$393.51 B 7.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$232.58 B-36.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$251.11 B-31.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.501 T 308.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$140.20 B-61.87%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$47.86 B-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$522.44 B 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$182.75 B-50.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$140.36 B-61.83%๐Ÿ‡ฌ๐Ÿ‡ง UK